Full Text View
Tabular View
No Study Results Posted
Related Studies
Mafosfamide in Treating Patients With Progressive or Refractory Meningeal Tumors
This study has been completed.
Study NCT00031928   Information provided by National Cancer Institute (NCI)
First Received: March 8, 2002   Last Updated: December 13, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Metastatic Cancer
Additional conditions recognized in this trial
Neoplasm Metastasis
More general conditions related to this trial
Neoplasms
Neoplastic Processes
Pathologic Processes
Interventions listed in this trial
mafosfamide
More general drug interventions related to this trial
Adjuvants, Immunologic
Antineoplastic Agents
Immunologic Factors
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
National Cancer Institute (NCI)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services